Scientists discover migrions that accelerate viral infections

Researchers have identified migrions, virus-like structures that enable faster and more severe viral spread by hijacking cell movement. These packages, formed in migrating cells infected with vesicular stomatitis virus, deliver multiple viral genomes simultaneously to new cells. The discovery challenges traditional models of infection and highlights increased disease potential in animal tests.

A team from Peking University Health Science Center and the Harbin Veterinary Research Institute has revealed a novel mechanism of viral transmission detailed in a study published in Science Bulletin. The research focuses on vesicular stomatitis virus (VSV), where infected cells pack viral genetic material and proteins into migrasomes—cellular structures that emerge during cell migration.

These migrasomes, containing viral nucleic acids and displaying the VSV surface protein VSV-G, form large virus-like entities dubbed "migrions." Unlike individual virus particles, migrions combine viral and cellular components, allowing for collective delivery. This bundling enables quicker replication in recipient cells, as multiple viral genomes arrive at once, initiating parallel infection processes.

Migrions stand out for their ability to transport more than one virus type simultaneously, differing from standard extracellular vesicle transmission. Upon reaching a new cell, they enter via endocytosis. Acidic conditions inside then activate VSV-G, prompting fusion with endosomes and release of viral contents to kickstart replication.

In mouse experiments, migrion-mediated infections proved far more potent than free virus exposure. Affected animals suffered severe lung and brain conditions, including encephalitis, often leading to fatal outcomes. This underscores the heightened pathogenicity of the migration-linked route.

The researchers describe migrions as a chimeric structure bridging viruses and migrasomes, introducing a migration-dependent transmission model. By exploiting the body's migratory systems, viruses can propagate more efficiently and systemically, potentially explaining rapid escalations in certain infections.

Related Articles

Realistic microscopic illustration of influenza viruses surfing along a human cell membrane before entry.
Image generated by AI

Scientists film influenza viruses ‘surfing’ into human cells in real time

Reported by AI Image generated by AI Fact checked

An international team led by ETH Zurich and including researchers in Japan has used a new high‑resolution imaging technique to watch, live, as influenza viruses penetrate human cells. The work shows that cells actively engage with the virus, helping to draw it inside in a process that resembles surfing along the cell membrane, and could inform the development of targeted antiviral therapies.

A new study reveals that giant viruses, like the mimivirus, encode parts of the cellular protein-making machinery, allowing them to direct their amoeba hosts more effectively. This capability blurs the line between living and non-living entities. Researchers suggest it enhances viral production even under stressful conditions.

Reported by AI

Scientists in Japan have discovered a giant virus called ushikuvirus that infects amoebae and provides evidence for the theory that viruses contributed to the evolution of complex cells. Isolated from Lake Ushiku, the virus exhibits unique structural and replication traits linking it to other giant DNA viruses. This finding, published in the Journal of Virology, deepens understanding of viral roles in eukaryotic evolution.

A large-scale study reveals that about one in ten people carry genetic variants making them more vulnerable to severe effects from the Epstein-Barr virus, which infects over 90 percent of the population. These variants are linked to higher viral persistence and increased risks of autoimmune diseases like multiple sclerosis and lupus. The findings, based on over 735,000 genomes, suggest pathways for targeted treatments and vaccines.

Reported by AI Fact checked

Researchers at Harvard’s Wyss Institute and Dana-Farber Cancer Institute report that a DNA origami-based vaccine platform called DoriVac generated robust immune responses in mice and in a human lymph node “Organ Chip” model. The team says the approach could be easier to store and manufacture than lipid nanoparticle–delivered mRNA vaccines, though the work remains preclinical. The results were published in Nature Biomedical Engineering.

Researchers at Stanford Medicine have created an experimental nasal spray vaccine that protects mice against multiple respiratory threats, including COVID-19, flu, bacterial pneumonia, and allergens. The vaccine activates the lungs' innate immune system for months, offering broad defense without targeting specific pathogens. Published in Science on February 19, the study suggests potential for human trials soon.

Reported by AI

Researchers at Fred Hutch Cancer Center have created human-like monoclonal antibodies that prevent Epstein-Barr virus (EBV) from infecting immune cells. Using mice engineered with human antibody genes, the team identified antibodies targeting viral proteins gp350 and gp42, with one fully blocking infection in lab models. The findings, published in Cell Reports Medicine, could lead to therapies for transplant patients at risk of EBV-related complications.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline